Both in Pharmaceuticals
Relmada Therapeutics vs Tilray Brands
Over the past year RLMD returned +58.4% and TLRY returned −81.1%; their daily moves had a correlation of 0.02.
RLMD +58.4% TLRY −81.1%Growth of $1, one year, split-adjusted
| Metric | RLMD | TLRY |
|---|---|---|
| Price | $3.58 | $2.53 |
| Market cap | $381.9M | $373.9M |
| Today | +4.07% | −4.17% |
| 1 month | −2.2% | −29.1% |
| 6 months | −53.1% | −58.9% |
| Year to date | −25.9% | −72.0% |
| 1 year | +46.1% | −81.4% |
| Revenue growth (YoY) | — | +22.7% |
| Gross margin | — | 30.1% |
| Net margin | — | −16.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.4× |
| Net cash | $217.7M | $16.6M |
| Dividend yield | — | — |
| Volatility (60d) | 58.2% | 47.1% |
| Short % of float | 14.0% | 14.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).